MFAM
BMY icon

Motley Fool Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Motley Fool Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Sell
175,529
-1,059
-0.6% -$60.8K 0.39% 49
2026
Q1 		$10.7M Sell
176,588
-39,880
-18% -$2.32M 0.46% 44
2025
Q4 		$11.7M Buy
216,468
+50,403
+30% +$2.42M 0.46% 48
2025
Q3 		$7.49M Buy
166,065
+66,489
+67% +$3.11M 0.31% 70
2025
Q2 		$4.61M Buy
99,576
+5,179
+5% +$254K 0.21% 93
2025
Q1 		$5.76M Buy
94,397
+2,046
+2% +$119K 0.32% 65
2024
Q4 		$5.22M Buy
92,351
+10,767
+13% +$602K 0.27% 76
2024
Q3 		$4.32M Buy
81,584
+2,821
+4% +$132K 0.26% 85
2024
Q2 		$3.25M Buy
78,763
+19,084
+32% +$854K 0.22% 88
2024
Q1 		$3.24M Buy
59,679
+3,648
+7% +$186K 0.21% 87
2023
Q4 		$2.87M Buy
56,031
+1,428
+3% +$75K 0.21% 89
2023
Q3 		$3.17M Buy
54,603
+4,799
+10% +$294K 0.25% 79
2023
Q2 		$3.18M Buy
49,804
+1,220
+3% +$81.8K 0.28% 70
2023
Q1 		$3.37M Buy
48,584
+1,486
+3% +$105K 0.37% 63
2022
Q4 		$3.39M Sell
47,098
-1,874
-4% -$141K 0.38% 64
2022
Q3 		$3.48M Sell
48,972
-300
-0.6% -$21.8K 0.34% 65
2022
Q2 		$3.74M Sell
49,272
-4,833
-9% -$368K 0.35% 66
2022
Q1 		$3.95M Sell
54,105
-3,072
-5% -$206K 0.29% 76
2021
Q4 		$3.56M Buy
57,177
+1,417
+3% +$83.1K 0.23% 88
2021
Q3 		$3.3M Sell
55,760
-222
-0.4% -$14.6K 0.21% 89
2021
Q2 		$3.74M Buy
55,982
+6,809
+14% +$444K 0.25% 84
2021
Q1 		$3.1M Sell
49,173
-3,743
-7% -$233K 0.22% 87
2020
Q4 		$3.28M Buy
52,916
+5,050
+11% +$311K 0.24% 82
2020
Q3 		$2.86M Buy
47,866
+6,007
+14% +$362K 0.25% 80
2020
Q2 		$2.46M Buy
41,859
+1,710
+4% +$102K 0.25% 73
2020
Q1 		$2.24M Buy
40,149
+490
+1% +$29.9K 0.29% 64
2019
Q4 		$2.55M Buy
+39,659
New +$2.27M 0.27% 66

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Motley Fool Asset Management's BMY Position: Q2 2026 in Review

Motley Fool Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 0.6% in Q2 2026, selling an estimated $60.8K and leaving 175,529 shares worth $10.1M. The position accounts for 0.39% of the portfolio, ranked #49.

Motley Fool Asset Management first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $11.7M in Q4 2025. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Motley Fool Asset Management held 175,529 shares of Bristol-Myers Squibb worth $10.1M as of Q2 2026.
  • Motley Fool Asset Management sold 1,059 Bristol-Myers Squibb shares in Q2 2026, an estimated $60.8K.
  • Bristol-Myers Squibb made up 0.39% of Motley Fool Asset Management's portfolio in Q2 2026, its #49 holding.
  • Motley Fool Asset Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
  • Motley Fool Asset Management's Bristol-Myers Squibb position peaked at $11.7M in Q4 2025.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Motley Fool Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.